About Jeremy Williams

This author has not yet filled in any details.
So far Jeremy Williams has created 13 blog entries.

Bujar et al 2019 – Quality decision making in Health Technology Assessment

Background: To evaluate the quality of the decision-making processes of pharmaceutical companies during medicines development for evidence generation to support reimbursement of new medicines and the appraisal recommendation decision-making process [...]

2021-01-18T17:07:01+00:00March 4th, 2019|Tags: , |

CIRS RD Briefing 66 – Benefit-Risk Assessment Tool (BRAT)

A structured approach to benefit-risk assessment is required as the cornerstone of a consistent way to evaluate and communicate observations regarding a medicine’s benefit-risk profile. The Benefit Risk Action Team [...]

2020-10-12T10:43:13+00:00January 1st, 2018|Tags: , |

Liberti et al 2010 – Progress on the development of a benefit-risk framework for evaluating medicines

CIRS authors write about benefit-risk in the March 2010 issue of Regulatory Focus by the Regulatory Affairs Professionals Society (RAPS). Article reproduced with the permission of RAPS. Download [...]

2020-10-12T10:41:12+00:00March 1st, 2010|Tags: , |
Go to Top